News & Insights

State Licensing Requirements for Controlled Substances

November 12, 2019

By Sharon Cusanza, MSN, RN, NEA-BC

State Licensing Requirements for Controlled Substances

With all of the publicity regarding the opioid crisis, state legislatures are creating laws requiring controlled substance education for prescribers. Furthermore, state licensing boards are ensuring compliance with these new laws. LAMMICO has produced a new series of controlled substance education to meet the requirements of Arkansas and Mississippi laws, in addition to our existing education for Louisiana prescribers. 

Arkansas providers have two requirements. Providers licensed after December 31, 2015 must complete a minimum of three hours of prescribing education within the first two years of licensure. Other providers must complete at least one hour of CME regarding the prescribing of opioids and benzodiazepines every year. To meet the needs of our insureds, we have created content to satisfy these requirements:

  • Newly-licensed Arkansas providers licensed after December 31, 2015 can take the education activity titled, “Controlled Substances Series: Arkansas Licensed Within Last 2 Years.” This course meets the three-hour re-licensure requirement for education on controlled substances.
  • For other Arkansas providers, see the one-hour, re-licensure education activity titled, “Controlled Substances Series: Arkansas License Renewals.” 
  • LAMMICO can also accommodate requests by large groups for a live presentation of this education.

Mississippi prescribers with an active DEA certificate need five hours of education on controlled substances. To satisfy this requirement, we have created a course for prescribers in Mississippi titled, “Controlled Substances Series: Mississippi License Renewals.

LAMMICO policyholders may access these courses free of charge by logging in as a Member at Once the course is completed, providers may print a CME certificate that they can submit to their state Board when applying for license renewal.

For more information, please contact the LAMMICO Risk Management and Patient Safety Department at 504.841.5211.

Recommended Reading For You

Annual Meeting of Policyholders

Read More

Recognizing and Addressing Signs of COVID-19-Related Depression in Your Patients

Read More

Key Employment-Related Questions as Medical Offices Reopen

Read More


Annual Reports:

Receive Regular Updates: